{
    "nctId": "NCT03681418",
    "briefTitle": "Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Breast Cancer.",
    "officialTitle": "Role of Ultrasound-Guided Lymph Node Biopsy in Axillary Staging of Breast Cancer.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Diagnostic accuracy of preoperative ultrasound-guided axillary lymph node biopsy for staging in patients with newly diagnosed breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed patients with operable breast cancer regardless of whether lymph nodes are suspicious or not.\n\nExclusion Criteria:\n\n* Patients who had previously undergone axillary surgery.\n* Patients with metastatic disease and not planned for axillary surgery.\n* Patients with a preoperative diagnosis of a benign lesion or ductal carcinoma in situ.\n* Patients with severe uncorrectable bleeding diathesis.\n* Patients refused to sign consent.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}